NaNOCure: a nanoparticle ointment to prevent infection and speed healing in burn wounds
Official title: NaNOCure: A Nanotechnology-Based Topical Therapy for Infection Control and Enhanced Burn Wound Healing
Funded at Nobiotics LLC · NIH-11309966 · Data updated 2026-11-12
A new topical nanoparticle ointment called NaNOCure is being developed to prevent infection, reduce inflammation, and speed healing for burn wounds at home.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nobiotics LLC NIH-funded |
| Lab location | 1 site (Raleigh, United States) |
| Project start | September 7, 2026 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $319,764 |
| NIH project number | 1R43GM163304-01 |
| Project ID | NIH-11309966 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are individuals with burn wounds at risk of infection who could use a safe, at-home treatment.
✕Less likely to help
Patients with burns requiring immediate medical interventions beyond topical therapy or with known sensitivities to the product components may not benefit.
What this research studies
Burn injuries affect millions worldwide and infection is a major risk. This project aims to create NaNOCure, a nanoparticle-based ointment that releases nitric oxide to fight bacteria, reduce inflammation, and promote tissue repair. It envisions an at-home treatment that could complement or replace some hospital-based care, potentially lowering costs and improving recovery times. The grant supports early-stage development and testing of the formulation and safety in preparation for broader clinical work.
Why it matters
Potential benefit: If successful, NaNOCure could reduce burn infection rates and accelerate healing, improving outcomes for patients and lowering healthcare costs.
How similar studies have gone: Previous work with nitric oxide-based topical treatments shows promise in antimicrobial and healing roles, but this exact formulation is novel.
Where this research is happening
-
Nobiotics LLC
Raleigh, United States Active
Researchers
- Principal investigator: Pant, Jitendra — Nobiotics LLC
- Study coordinator: Pant, Jitendra
Related research
Other NIH-funded projects on the same topics.
-
Immunomodulatory therapy to speed up healing after oral cavity injuries in kids
A new approach using a drug called FTY720 aims to improve healing and reduce pain after oral injuries or palate surgery in children.
-
Aiming to slow dangerous lung inflammation to help fight bacterial infections like tuberculosis
A patient-facing program tests whether stopping a specific inflammatory cell (Spp1+ macrophages) from overreacting can help control tuberculosis and possibly improve outcomes in other inflammatory diseases.
-
Engineered protein materials to study wound healing and blood vessels
A researcher team at the University of New England is studying how the environment around a protein changes its behavior to better understand wound healing and blood vessel formation.
-
Understanding how healing tissue uses tiny messengers and scaffolds to repair wounds
A study to learn how cells talk to each other and how tiny vesicles and the extracellular matrix help skin wounds heal better.
-
Hormone signals and sex differences in how wounds heal
This grant explores how male- and female-specific hormones affect wound healing and scarring, with the goal of improving treatments for people who heal poorly.
-
Therapeutic extracellular vesicles to boost skin wound healing
A research grant is exploring how tiny cell messengers called extracellular vesicles can be engineered to improve skin wound repair in injury models.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.